Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Taysha Gene Therapies (TSHA) Other Non Operating Income: 2022-2024

Historic Other Non Operating Income for Taysha Gene Therapies (TSHA) over the last 3 years, with Dec 2024 value amounting to -$110,000.

  • Taysha Gene Therapies' Other Non Operating Income rose 460.49% to $292,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $286,000, marking a year-over-year increase of 100.44%. This contributed to the annual value of -$110,000 for FY2024, which is 100.32% down from last year.
  • Latest data reveals that Taysha Gene Therapies reported Other Non Operating Income of -$110,000 as of FY2024, which was down 100.32% from $34.7 million recorded in FY2023.
  • In the past 5 years, Taysha Gene Therapies' Other Non Operating Income ranged from a high of $34.7 million in FY2023 and a low of -$110,000 during FY2024.
  • In the last 3 years, Taysha Gene Therapies' Other Non Operating Income had a median value of -$18,000 in 2022 and averaged $11.5 million.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first skyrocketed by 192,977.78% in 2023, then slumped by 100.32% in 2024.
  • Taysha Gene Therapies' Other Non Operating Income (Yearly) stood at -$18,000 in 2022, then skyrocketed by 192,977.78% to $34.7 million in 2023, then tumbled by 100.32% to -$110,000 in 2024.